Recent News

• 03.30.2026 - Culture in Action: What Makes Fortrea, Fortrea
• 03.30.2026 - Contact
• 03.26.2026 - Ophthalmology Gene Therapy Trial: Insights from a Senior Clinical Project Manager
• 03.26.2026 - Biosimilars, regulatory flexibility and why CMC data matters more than ever
• 03.25.2026 - ASGCT 2026
• 03.25.2026 - Clinical Pharmacology Services: Data Visualization Tool
• 03.25.2026 - Clinical Trial Data Visualization
• 03.24.2026 - Phase 1b studies. Speed vs. success: What should small biotechs weigh up before moving to patients?
• 03.24.2026 - Fortrea Intelligent Technology Foresight Solutions
• 03.24.2026 - Fortrea Intelligent Technology Companion Solutions

Recent Filings

• 03.26.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.24.2026 - 4 Statement of changes in beneficial ownership of securities